10
Dec
2024

Zeta Pharma

Exhibitor at CPHI Middle East 2024 stand 1.C56
About Us

ZETA PHARMA®, established in 2010, brings significant value to Egypt's pharmaceutical industry.
ZETA PHARMA® is the highest growing in the top 100 Egyptian pharmaceutical companies during the last 4 years with CAGRS 112% (IQVIA)
ZETA Pharma boasts a state-of-the-art manufacturing facility built to WHO cGMP standards. Our collaboration with the European Bank for Reconstruction and Development (EBRD) underscores our commitment to excellence and innovation. 
ZETA PHARMA® is present in 30 countries to empower global health wit...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • EG
  • 2019
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Association/Government
Contract Service
Distributor/Import Export
OTC
Pharmaceutical company
Wholesale/Retail
Primary activities
Contract Manufacturer
End-product distributor (Wholesale)
Finished Formulation products Distributor/Buyer
Nutraceuticals
Pharmaceutical Company (generic finished products)
Regulatory Affairs
View company profile
Contact info
  • +201022228221
  • Website
  • 36 Al Sheikh Mohammed Al Nadi St.,, Off Mostafa El Nahas St. 6th District., Nasr City, 11371, Cairo, Egypt
Show contact info Hide contact info
Event information
CPHI Middle East 2024
  • 10 Dec 2024 - 12 Dec 2024
  • Riyadh Front Exhibition & Convention Center Riyadh, Saudi Arabia
  • Visit us at stand 1.C56

Products Featured at CPHI Middle East 2024

  • Nexicure - esomeprazole 40 mg and 20 mg MUPS tab

    Product Nexicure - esomeprazole 40 mg and 20 mg MUPS tab

    Nexicure 40 mg and 20mg MUPS tabPack: 20 tab
    Category: proton pump inhibitors (PPIs)The first and only PPI - Esmoperazole 40 mg and 20mg tab generic with MUPS technology 
    Indication: It is used to treat gastroesophageal reflux disease GERD, peptic ulcer disease, and&nbs...
  • Vonseca - vonoprazan 10mg and 20 mg tab

    Product Vonseca - vonoprazan 10mg and 20 mg tab

     Vonoprazan is a potassium-competitive acid blocker (PCAB). It competitively inhibits the binding of K ions to hydrogen/potassium-adenosine triphosphate (H+/K+-ATPase) enzyme system that acts as the proton pump of the gastric parietal cell, thereby inhibiting gastric acid production belong to the prot...
  • Elimbosis - apixaban 2.5mg and 5 mg tablet

    Product Elimbosis - apixaban 2.5mg and 5 mg tablet

    Elimbosis 5 mg tab - apixaban 5 mg Pack: 30 tab
    Category: is an anticoagulant.Indications: Apixaban is used for the following:
    1-To lower the risk of stroke and embolism in people with non-valvular atrial fibrillation.
    2-Deep vein thrombosis (DVT) preve...
  • Integrated Solution of Full Range of Empagliflozin in the management of type 2 diabetes.

    Product Integrated Solution of Full Range of Empagliflozin in the management of type 2 diabetes.

    Empagliflozin, a potent SGLT2 inhibitor, stands out in the management of type 2 diabetes (T2D). It reduces glucose reabsorption in the kidneys, leading to increased urinary glucose excretion. Studies highlight its efficacy as monotherapy, effectively lowering HbA1c levels and promoting weight loss, making ...
  • Nexicure Sachets, Esomeprazole Sachets: 2.5mg, 5mg, 10mg, and 20mg

    Product Nexicure Sachets, Esomeprazole Sachets: 2.5mg, 5mg, 10mg, and 20mg

    • Age Group for Every Concentration

    • 2.5mg: Suitable for infants and children aged 1 month to less than 1 year. • 5mg: Recommended for children aged 1 to 5 years. • 10mg: Suitable for children aged 6 to 11 years. • 20mg: Designed for adolescents aged 12 years and older, as well as adults. ...

Zeta Pharma Resources (1)

  • Zeta Pharma Company Profile

    Brochure Zeta Pharma Company Profile

     ZETA PHARMA® is the leading branded generic from Egypt

    ZETA PHARMA®, established in 2010, brings significant value to the  pharmaceutical industry in Egypt, Africa, Middle East and CIS regions.

    ZETA PHARMA® is the fastest-growing company in the top 100 Egyptian pharmaceutical companies during the last 4 years with CAGR % 112 ( IQVIA.)

    ZETA PHARMA® boasts a state-of-the-art manufacturing facility built to WHO cGMP standards.

    ZETA PHARMA®, in a groundbreaking partnership with the European Bank for Reconstruction and Development (EBRD), has embarked on an ambitious project to secure EMA accreditation. This endeavor underscores our unwavering commitment to excellence and innovation, setting new standards in the pharmaceutical industry.

    ZETA PHARMA®, offer advanced manufacturing meets cutting-edge pharmaceutical solutions, empowering health and wellness across the globe...